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Since the 1950s the number of psychotropic medications
available has increased.1 Drug treatments showed utility
for psychoses2 and depression,3 although arguably the
beneﬁt has been overvalued.4-6 By contrast, there is little
evidence of utility for people with personality disorder.
Current guidelines give limited support for medication7-9
and no clear justiﬁcation for long-term medication.10,11
Consequently, psychiatrists encounter patients with
personality disorder with persisting symptoms, disability
and unmet needs.12 In addition, drug treatments have to be
considered repeatedly and despite guidance many patients
are treated largely or entirely with medication. There is
evidence of high rates of polypharmacy for patients in
secondary care mental health services13-15 and evidence that
prescribing for patients with personality disorder may vary
according to the severity of symptoms, the risks of offending
behaviours and with service contexts.16
The UK National Institute for Health and Care
Excellence (NICE) guidelines on borderline and antisocial
personality disorders17,18 provide aspirational frameworks
intended to standardise practice. Those guidelines pay lip
service to relational issues in consultations but cite little
evidence for this. Exploration of doctors’ decision-making is
increasing19 and research suggests that doctors frequently
deviate from clinical guidelines for many reasons, including
sound clinical appraisal.20-23 However, evidence about how
prescribing decisions are made by psychiatrists is very
limited by comparison with the volume of randomised
controlled trial (RCT) research evaluating medication.
This study sought to explore consultants’ experiences
of and views on prescribing for patients with personality
disorder, applying a thematic analysis to ﬁnd the themes
that were important to participants and which emerged
consistently.
Method
Participants
The study was approved by a National Health Service (NHS)
research ethics committee. Interviews with 11 consultant
psychiatrists were conducted in 2010. The consultants
worked in community mental health teams, crisis and
home treatment teams, assertive outreach, rehabilitation
services, acute in-patient services and forensic services
(predominantly high secure).
Procedures
All interviews were conducted by L.M. using a semi-
structured schedule and interviews lasted up to 1 h.
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Aims and method To explore experiences of psychiatrists considering medication
for patients with personality disorder by analysis of transcribed, semi-structured
interviews with consultants.
Results Themes show important relational processes in which not prescribing is
expected to be experienced as uncaring rejection, and psychiatrists felt helpless and
inadequate as doctors when unable to relieve symptoms by prescribing. Discontinuity
in doctor-patient relationships compounds these problems.
Clinical implications Problems arise from: (a) the psychopathology creating
powerful relational effects in consultation; (b) the lack of effective treatments, both
actual and secondary to under-resourcing and neglect of non-pharmaceutical
interventions; and (c) the professionally constructed role of psychiatrists prioritising
healing and cure through provision of technological interventions for speciﬁc
diagnoses. There is a need for more treatments and services for patients with
personality disorder; more support and training for psychiatrists in the relational
complexities of prescribing; and a rethink of the trend for psychiatrists to be seen
primarily as prescribers.
Declaration of interest None.
Prescribing for personality disorder: qualitative
study of interviews with general and forensic
consultant psychiatrists
Lawrence Martean,1 Chris Evans1
116
Questions were asked to elicit factors which inﬂuenced the
participants’ experiences during consultations about
prescribing for patients with personality disorder (e.g.
what aided decision-making, what did not help and any
factors which they experienced as barriers to effective
decision-making) and were asked to reﬂect on the
emotional aspects of these experiences and their views on
how their feelings effected their communications, actions or
decisions. The interview focused on how the experience
differs from prescribing for Axis I disorders.
Data analysis
Interviews were transcribed and analysed by L.M. using
thematic analysis.24,25 Analysis started with coding of initial
themes for manifest data which occurred commonly and
writing memos about latent content for possible emergent
themes. The ﬁrst six interviews were fully analysed to
develop a coding frame and subsequent interviews analysed
using this. Theme saturation was reached with no new
major themes arising from the ﬁnal transcript. The ﬁrst six
interviews were read in full by C.E. and code development
was checked and discussed. Disagreements largely took the
form of adding codes rather than any disagreements about
use of codes. For the remaining interviews, memos made
by L.M. were reviewed to establish whether new themes
should be included, and coding that felt debatable was
discussed.
Results
There were four main themes consistently present across
the transcripts, with 13 subthemes (Fig. 1). The results are
detailed below by presenting segments of the interview
transcripts which are examples of the same units of text
used for coding during analysis to produce the ﬁnal themes
and subthemes.
Difficulty collaborating in emotionally charged
consultations
Participants repeatedly described being unable to reach
satisfactory agreement with patients regarding prescribing,
and most described examples of high levels of distress and
conﬂict in some consultations. The core tension was
between making a clinically sound but unpopular decision
or agreeing to prescribe to attempt to preserve a positive
doctor-patient relationship.
Difficulty in collaborative agreement of prescriptions
with patient
‘He just would not accept being on no medication. Of course I
could just not prescribe, I could just say it doesn’t matter what
you say, I am not going to prescribe anything. I just didn’t feel
able to do that. It seemed that if he didn’t get that, he wasn’t
going to engage’ (P10).
‘It just felt to me that the projection was so strong to the point
that the person was telling me that they thought I had the
same eyes as their abusive father. It was just getting corrosive
really so I asked for that person to be taken over by someone
else’ (P6).
Fearing escalation of distress following non-prescription
Many psychiatrists described a feeling of dread, anticipating
high-emotion responses and conﬂict about not prescribing.
‘Sometimes they will be really angry or upset if they are not
getting what they want, they storm out of your ofﬁce or start
shouting at you or things like that’ (P4).
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Subthemes
. Feeling helpless when unable to
prescribe
. Feeling not good enough as a doctor
. Need to do something
. The struggle to maintain utility of a
guideline- and diagnosis-based
treatment approach
Subthemes
. Difﬁculty in collaborative
agreement of prescriptions with
patient
. Fearing escalation of distress
following non-prescription
. Feeling a pressure and expectation
to prescribe
Subthemes
. The creation of an obscure
diagnostic and treatment
narrative
. Feeling stuck with established
prescriptions
. Effects of contrasting
prescribing styles and different
prescribing contexts
Subthemes
. Prescribing conveys care,
empathy, understanding and belief
in the patient
. Prescription as a perceived transfer
of responsibility
. Balancing pharmacological
and psychological modes
of helping
Difﬁculty collaborating in
emotionally charged
consultations
Experiences of
prescribing for
personality disorder
Feeling helpless when
unable to relieve
suffering
Drug as facilitator in the
doctor-patient
relationship
Effects of discontinuity
of doctor-patient
relationship
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Fig 1 Summary of results.
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Feeling pressure and an expectation to prescribe
Intense pressure could come from the patient, relatives,
colleagues or society, but also from within. Some
participants felt more conﬁdent than others to resist these
pressures and several felt resisting was dependent on the
context in which they were practising.
‘They see you as a doctor, they see you as a prescriber. They
know you are a psychiatrist. Patients come to see you knowing
that you can prescribe’ (P2).
‘It is difﬁcult, you are in a team aren’t you, you feel an
obligation to protect your nursing staff but you have got to do
what is best haven’t you, and your ﬁrst responsibility is to your
patient and you have got to do what is best for them regardless
of [the] kind of other pressures that come’ (P8).
Some described concerns for their own safety, especially in
forensic services.
‘If she wants to talk about medication, we get lots of staff who
stand very close and I stand very, very far away because she has
already kicked me once and I am not making that mistake
again’ (P11).
Feeling helpless when unable to relieve suffering
There were many quotes highlighting helplessness and
powerlessness when faced with a patient who is
suffering. Pressures included feeling restricted by
guidelines, not having the time or the expertise to
offer non-pharmacological interventions and having poor
access to psychological treatments.
Feeling helpless when unable to prescribe
‘There is something really sad when you have got someone
sitting in front of you saying please help me, but it is a long-
term problem that you can help in the long-term but you can’t
do anything there and then. They are so used to being told in
prisons particularly, well try this pill, and it hasn’t worked. So
that is really difﬁcult - that sense of helplessness at that point’
(P11).
‘What can you offer to them? Well I can refer you to the
[psychological therapy] group, but it is a group and you have to
be assessed and there is a few months’ waiting list. It doesn’t ﬁt
with the need of the patient at the time. There is something
about containing the situation here and now, which you think
is all there on your shoulders’ (P1).
Feeling not good enough as a doctor
‘They are expecting to be given a prescription because they are
seeing a doctor. When you tell them "no" then they say, well
why did we come here, what was this appointment for, are you
doing your job properly, you don’t understand what is going
on’ (P4).
‘I think that personally I have found it incredibly difﬁcult
because I have felt that I have failed; as a doctor I have failed
to alleviate someone’s distress and in many regards maybe I
have made it worse’ (P2.)
The need to do something
‘On occasions I don’t actually need to do anything. And that is
actually quite a hard lesson for a medic. I think you know that
you can end a consultation and say, ‘‘Well I am sorry you feel
like this; hopefully things will change. I am going to see you
again in 2 months’’. That is actually very hard for medics to do,
because what we want is for people to actually be able to say,
‘‘Well thank you doc, I feel much better’’, and go’ (P2).
‘At one level I am responding to a request for help and often
the request comes in a language - I don’t really care what you
do, just make things better for me’ (P7).
The struggle to maintain utility of a guideline-
and diagnosis-based treatment approach
‘I think some clinicians in some places are keener to call
something psychosis perhaps when it doesn’t look like that to
me, so that they can then prescribe safely . . . and I can sort of
understand that approach from clinicians really that a severely
personality disordered individual with impulsivity or whatever
might, with a particular type of voice which might be normally
thought of as a personality type of voice, might be called
psychotic, so that you can then prescribe for it’ (P8).
‘For me, personality disorder is much more symptom led - it is
much more about level of disability by symptoms, severity of
symptoms and then going with a means to an end, [prescribing]
as an adjunct to get them into a psychological treatment so it is
not diagnostic led, I don’t think, prescribing in [personality
disorder]’ (P5).
‘They often produce very polarised views among staff, and
sometimes among doctors as well about, well, what is this: is it
schizophrenia, is it borderline personality disorder, how should
we be managing this, surely we should be taking them off their
medication, sending them away and saying they have
responsibility for themselves, etc., etc.? And other staff will
say, ‘‘No, this person is psychotic, they need our paternalistic
medicalised care’’ ’ (P3).
Effects of discontinuity in the doctor-patient
relationship
The creation of an obscure diagnostic and treatment narrative
‘Patients tend to come in on a huge raft of different
medications because they tend to have failed elsewhere, by
which time they will have accrued six or seven different kinds
of medications. They don’t know which one is helpful, they
don’t know if anything is helpful in the least anyway’ (P11).
‘Well I suppose they will be on medication from every group -
antidepressant, mood stabiliser, antipsychotic. That is often
the case, with not a very clear rationale. If you were not the
one who did this prescribing, then it is hard to actually see by
retrospectively searching through the notes, what was started
at which point and why. Things seem to be just added and I
think it reﬂects that people felt that we just need to do
something . . .well this doesn’t work so I’ll add this, or this
doesn’t work so I’ll add another’ (P1).
The psychiatrists working in acute care gave stark warnings
about the effects of fragmented patient journeys through
services with rapid changes in doctor-patient relationships.
‘When [patient care] gets chopped up and broken into different
people making all the decisions I think it leads to quite a bit of
anxiety and lack of containment that can put people into crises
and lead to inappropriate prescribing [. . .] We know that
consistency is probably the most important thing, and that is
something that has been very much lost in our services’ (P3).
Feeling stuck with established prescriptions
‘When patients have been misdiagnosed and been given lots of
different medications, then to try and gradually work in the
idea that this is a longstanding problem ingrained into their
personality and maybe we should look at other treatment
options. I suppose trying to focus on other treatment options
is, umm, is that they don’t really like to be told that. If they
have just been told that medication is the only thing for them
and you are taking it away, it may feel as though you are taking
all help away from them and there are no sort of alternatives’
(P4).
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Effects of contrasting prescribing styles and different
prescribing contexts
‘If that person goes from one to another service, to another
psychiatrist then gets very different views, that can make life
very hard for the people. They feel very uncontained, they
don’t know what’s right, what’s wrong, and they’ll much more
often be attracted to the more medical model of their care
because of the potential, the ongoing potential for instant
rewards’ (P3).
The drug as a facilitator in the doctor-patient
relationship
Prescribing conveys care, empathy, understanding and belief
in the patient
The participants gave detailed insights into how the act of
prescribing is inseparable from the relational processes in
consultations with patients with personality disorder.
‘It was very difﬁcult to not give him medication, because he
wanted it so much and it seemed to be all linked up with ‘‘If
you don’t give me medication then you don’t believe that I am
ill and so you are rejecting me’’ [. . .] I think medication is like
the milk, the mother’s milk, and we have to wean him off quite
slowly’ (P9).
‘It is just an issue when you are trying to reduce it, because if
their view of themself is that they are ill, and they need to be ill
to get care and they see a reduction in their medication as a
sign that everyone thinks that they are not ill, then I think that
causes them panic and can destabilise them’ (P10).
‘Making the doctor feel that they have actually done some-
thing, so everyone brieﬂy feels better, although ultimately the
patient doesn’t beneﬁt from that. What the patient may have
beneﬁtted from in the short term at least is being heard, yeah,
and that prescribing might be part of that process I guess. But
what I am saying is that if we can work with them consistently,
that sense of them needing to be heard by giving them
medicine needs to be removed from the equation. We need to
hear them, and the way we hear them is by spending long
enough with them to not give them medication’ (P2)
Prescription as a perceived transfer of responsibility
‘I think by giving people tablets if you are not careful you do
remove that sense of responsibility. It is almost like, these
tablets aren’t working therefore it is the doctor’s fault that I hit
that person’ (P1).
‘On the one hand you are saying you should be responsible for
your actions and you have got to work in this way, but on the
other hand you are giving them a slightly mixed message which
is we’ll put you on these tablets so you have got an illness, you
know, that sort of conﬂict. I think it is much more complicated
if you are prescribing and the patient had got a prescription
because of the power, the powerful symbolism of that and the
fact that self-harming can arise from that [. . .] It feels different
if someone self-harms with something you have given to them,
than with something you haven’t given to them [. . .] I think
that can be a very powerful thing between the doctor and the
patient if they are potentially going to self-harm with what you
are giving them’ (P10).
Balancing pharmacological and psychological modes of helping
‘She does become very dissociated and it is difﬁcult for us to
have any kind of conversation. If we do have a conversation she
often can’t respond to me - it’s me just being with her really
and trying to talk to her but then often after the event she can’t
remember an awful lot of what I have said to her [. . .] I can’t
negotiate any kind of care plan with her because she is so
distracted she can’t really talk. So when people are that kind of
distracted and dissociated I think that medication can be
useful so you can just start to even think about a plan together’
(P10).
‘My approach to prescribing is that in order to get them into
the psychological therapy, get their, reduce their level of
arousal, reduce their level of paranoia, reduce their level of
kind of emotional dysregulation, I will prescribe some
medication to get them into the treatment and then I will
start to, as they acquire psychological skills, I will then tail off
the medication’ (P5).
Discussion
These ﬁndings support the view that managing medication
and achieving collaborative decision-making for patients
with personality disorder is complex and challenging. This
seems consistent with the ‘mentalisation’ model that highly
distressed patients, particularly with borderline pathology,
are unable to reﬂect on their own mental states or those of
the doctor,26 a capacity probably necessary for negotiation
and agreement. The doctor may possess a great desire to
help and relieve suffering based on both personal experi-
ence and training, and the wish to do something can become
a problem when faced with a patient who does not appear to
get better.27 This impulse to do something, which may be
helpful with other patient groups, may provide a disabling
complementarity between doctor and patient.
Bateman & Fonagy describe the ‘non-mentalising’
patient who is prone to interpret only physically observable
actions as evidence of changes in mental states of others,
meaning that prescribing may be felt as the only evidence of
genuine care and concern. In mentalisation terminology,
the ‘teleological mode’ of relating28 may be likened to
a phenomenon in which ‘actions speak louder than words’.
This may help explain why psychiatrists sometimes use
prescribing as a way of communicating empathy and
establishing rapport with the patient when there may
be mutually high emotional arousal during difﬁcult
consultations.
It is clear from these interviews that consultants
experience consultations with patients with personality
disorder as emotionally charged and that doctors sometimes
prescribe to preserve a good doctor-patient relationship.29
Clinical guidelines do not adequately take into account the
relational aspects of prescribing, leaving doctors struggling
to follow prescribing guidance when under great pressure to
do something.30
This study also highlights the uncertainty that
psychiatrists experience when attempting to practice
within a diagnosis-based treatment paradigm for the most
complex and challenging patients, with sometimes very
little apparent utility of diagnosis in informing the actual
prescribing decisions. The social and professional
construction of the diagnosis of personality disorder
may be controversial31 but can be difﬁcult to question
in the heat of the consultation and may set up a role for
the psychiatrist as ‘healer’, endowed with expectations of
cure relating to diagnosis not to problems - and there is
evidence that problems as much or perhaps more than
diagnosis may be crucial to explore for patients with
personality disorder.32-34 A shift to consider problems and
states rather than diagnoses may be congruent with new
views of the action of psychotropic drugs as modiﬁers of
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general mental states rather than treatments for illness-
speciﬁc pathology.35
The study underlines that ‘non-patient factors’36 can be
strong determinants of prescription patterns, including:
access to psychological treatments and specialist services,
prescriber view of medication effectiveness and the type of
institution in which the patient is encountered.37 The
ﬁndings also suggest that the lack of continuity of the
doctor-patient relationship obscures diagnosis, leads to
difﬁculty in modifying established prescriptions and may
predispose to crises resulting in overprescribing. Evidence
of high rates of polypharmacy in this group is gathering
strength and the phenomenon of overtreatment in medicine
in general is increasingly recognised38,39 and the many
reasons for this need more exploration.
This study sheds light on reasons why prescribing
practice for patients with personality disorder may not be
helped much by guidelines, whose evidence base is limited
to RCTs using highly select groups of patients. Guidelines
do not foster a range of empirical exploration of prescribing
relationships and complexities as highlighted in this study
and this underlines a recent call for a paradigm shift in
psychiatry.40
Strengths and limitations of the study
Researcher biases in the interviews and analysis may
inﬂuence the ﬁndings. The usual steps were taken to try
to limit these by using a semi-structured interview schedule
and by C.E. cross-checking the analysis. Of course, this will
only restrict bias, not eliminate it, and we are both
psychiatrists with Certiﬁcates of Completion of Training
in psychotherapy, with a particular interest in interpersonal
and affective processes. L.M. has been recently working in a
range of in-patient and community mental health service
contexts involving consultations with patients with
personality disorder when he would make prescribing
decisions as part of the role. C.E. has worked largely with
patients with personality disorder since about 1990 and
believes short-term use of medication has an important role
in work with patients with personality disorder, although
his own posts over the past 15 years have not involved
prescribing. He is involved in a Health Technology
Assessment RCT of mood-stabilising medication for
patients with personality disorder.
The sample included psychiatrists from a broad range
of services and the themes identiﬁed were present across
the majority of interviews giving conﬁdence they were
general, and we felt that thematic saturation was reached.
However, the sample was taken from a single trust, although
local characteristics would seem fairly generalisable - and
the sample was restricted to consultants. Replication in
other areas and with extension to non-consultant grades
and trainees and with more psychiatrists specialising in
work with patients with personality disorder would be
valuable. Research into the experiences of other mental
health professionals involved with patients with personality
disorder should be sought, as triangulation of the doctor-
patient relationship in modern multidisciplinary work was a
clear and important theme.
Implications
Our ﬁndings support the need for further review of the
current approach to providing treatments within NHS
services for patients with personality disorder and provide
an alternative perspective to the predominantly quantitative
research on this topic. The ﬁndings show that affective as well
as cognitive processes affect consultations, and prescribing
decisions may be powerfully inﬂuenced by emotional factors
in the relationship between doctor and patient. Even
experienced consultant psychiatrists can feel ill equipped
discussing medication with some patients. The study
indicates that psychiatrists attempt to use medication in
highly considered ways, for example to enhance engagement
and improve ability to access psychological treatments and
to manage crises. More research is needed to establish when
such tailored prescribing is effective and when and how best
to provide these interventions.41
Research is also needed into how prescribing decisions
and patient care might be improved by training and by
specialist supervision and support for psychiatrists in
managing the emotional demands of these consultations.
More research is also required into the experiences of those
in other roles in relation to consultations about prescribing
with patients with personality disorder, particularly
patients themselves, carers, nurses, trainee psychiatrists
and general practitioners.
The study suggests that the current NICE guidance for
personality disorder is in need of signiﬁcant review and
updates. In particular, it needs to allow more for the
diversity and complexity of the patients presenting and the
variety of treatment contexts in which psychiatrists provide
this care, but also to foster empirical research into
prescribing and discussion of management options so that
guidance on this is based on empirical data as much as
choices between medications is based on sound double-
blind RCT evidence. This is not about criticising the RCT for
medication but about recognising that pressures on NICE
lead its guideline development processes and particularly its
hierarchy of evidence to be skewed far out of line with its
true epistemological needs.42,43
Although ‘helper helplessness’ may be common and
sometimes inevitable in this area, this study highlights the
need to improve access to, and provision of, specialist
services and effective psychological treatments to avoid
psychiatrists feeling there is no alternative but to prescribe.
This may support the argument for psychiatrists themselves
taking back some of the lost role of providing psychological
support and intervention, alongside pharmacological
overview, to help them feel less expectation to prescribe
and give them tools to provide care at times and situations
when drug treatments options are not indicated.
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